• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Pseudolaric Acid B

Pseudolaric Acid B

Product ID P7219
Cas No. 82508-31-4
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $178.60 In stock
5 mg $802.10 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Psuedolaric acid B (PAB) is a diterpene acid found in the root bark and trunk bark of Pseudolarix kaempferi. PAB exhibits anticancer chemotherapeutic, immunosuppressive, anti-angiogenic, anti-inflammatory, and antifungal activities in a variety of models. In vitro, PAB activates caspases 3 and 9, upregulates Bax and Bad, and downregulates Bcl-2 and Bcl-xl, inducing apoptosis. PAB also increases PKC activity, inducing cell cycle arrest, autophagy, and senescence in cancer cell lines. In other models, PAB competitively inhibits tubulin assembly, preventing formation of mitotic spindles and microtubule polymerization. In animal models with tumor xenografts, this compound decreases tumor weight. Additionally, PAB downregulates expression of pro-angiogenic factors such as VEGF, HIF-1α, and cyclin E. PAB decreases IL-2 production by T cells and inhibits T cell proliferation in vitro. This compound also inhibits translocation of NF-κB and expression of cyclooxygenase (COX-2), decreasing production of prostaglandin E2 (PGE2). PAB displays antifungal activity against a variety of fungi both in vitro and in vivo.

Product Info

Cas No.

82508-31-4

Purity

≥98%

Formula

C23H28O8

Formula Wt.

432.46

Chemical Name

(2E,4E)-5-[(1S,7S,8S,9R)-7-acetyloxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid

IUPAC Name

(2E,4E)-5-[(1S,7S,8S,9R)-7-acetyloxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid

Synonym

PAB

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P7219 MSDS PDF

Info Sheet

P7219 Info Sheet PDF

References

Pseudolaric acid B induces caspase-dependent cell death in human ovarian cancer cells. Yu B, Yue DM, Shu LH, Li NJ, Wang JH. Oncol Rep. 2013 Nov 25. [Epub ahead of print]. PMID: 24276652.

Role of pseudolaric acid B in A549 lung cancer cell proliferation and apoptosis. Guan T, Yang Y. Mol Med Rep. 2014 Jan;9(1):144-8. PMID: 24248012.

Yu Jh, Liu Cy, Zheng Gb, et al. Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma l929 cell. Int J Med Sci. 2013 Apr 9;10(6):707-18. PMID: 23630435.

Sarkar T, Nguyen TL, Su ZW, et al. Interaction of pseudolaric acid B with the colchicine site of tubulin. Biochem Pharmacol. 2012 Aug 15;84(4):444-50. PMID: 22634405

Wei N, Li T, Chen H, Mei X, et al. The immunosuppressive activity of pseudolaric acid B on T lymphocytes in vitro. Phytother Res. 2013 Jul;27(7):980-5. PMID: 22893196.

Liu J, Guo W, Xu B, et al. Angiogenesis inhibition and cell cycle arrest induced by treatment with Pseudolarix acid B alone or combined with 5-fluorouracil. Acta Biochim Biophys Sin (Shanghai). 2012 Jun;44(6):490-502. PMID: 22551583

Hou L, Xu B, Guo W, et al. Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells. J Cancer Res Clin Oncol. 2012 Feb 8. [Epub ahead of print]. PMID: 22314698.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • H9613

    N-(4-Hydroxyphenyl)retinamide

    Retinol (vitamin A) analog, binds RBP4; Des1 in...

    ≥98%
  • T3197

    L-Thyroxine Sodium Pentahydrate

    Endogenous thyroid hormone T4.

    ≥97%
  • C0044

    CAL101

    p110δ PI3K inhibitor.

    ≥99%
  • E5219

    Endothelin-1, human

    Endogenous peptide involved in vascular contrac...

    ≥95%
  • T1027

    2’-Benzoylcarbonyl D-seco-Taxol

    2’-Benzoylcarbonyl D-seco-Taxol is an impurit...

    ≥90%
  • T3568

    Tirasemtiv

    Fast skeletal muscle troponin complex activator...

    ≥99%
  • P4008

    PKC412

    Staurosporine derivative; PKC and FLT3 inhibito...

    ≥98%
  • G6817

    Green Tea Polyphenols

    Extract containing catechins and flavonoids fou...

    ≥98%
  • M9608

    Myclobutanil

    14-α demethylase inhibitor.

    ≥97%
  • A0916

    Acepromazine Maleate

    Phenothiazine derivative; D1/2 and 5-HT1A/2A an...

    ≥99%
  • C4535

    Clinafloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • D0263

    Dapoxetine Hydrochloride

    SERT inhibitor, potential voltage-gated K+ chan...

    ≥99%
  • D0368

    2-Epi-16-deoxysarcophine

    Cembranoid found in Sarcophyton.

    ≥98%
  • S0269

    SAR245409

    Pyridopyrimidinone; PI3K and mTOR inhibitor.

    ≥96%
  • X4402

    XL-147

    Dual inhibitor of PI3K and mTOR.

    ≥98%
  • E5241

    Met-Enkephalin

    Endogenous opioid peptide; δOR and μOR agonis...

    ≥95%
  • D8014

    DU-14

    Steroid sulfatase inhibitor.

    ≥98%
  • C0172

    Carbimazole

    Methimazole prodrug; thyroid peroxidase inhibit...

    ≥98%
  • C0253

    Candesartan

    AT1 inhibitor.

    ≥98%
  • M4200

    MK-0752

    γ-Secretase inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only